Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GLWL-01 in Prader-Willi Syndrome
NCT03274856Phase 2Completed
- Sponsor
- GLWL Research, Inc.
- Start
- Feb 2018
- Primary completion
- Jun 2019
- Countries
- 2
01
Overview
Phase 2, randomised, double-blind trial of GLWL-01 in Prader-Willi syndrome (PWS) (2 arms), sponsored by GLWL Research, Inc. Primary endpoint: Hyperphagia Questionnaire for Clinical Trials at 4 weeks. Started Feb 2018; status: completed.
02
Drugs
GLWL-01
03
Conditions
Prader-Willi syndrome (PWS)
Beyond the preview
Go deeper on NCT03274856.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03274856.